Proxalutamide (GT0918) Treatment for Outpatients With Mild or Moderate COVID-19 Illness

NCT04870606 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

733

Enrollment

INDUSTRY

Sponsor class

Conditions

Efficacy and Safety

Interventions

DRUG: Proxalutamide (GT0918)
DRUG: Placebo

Sponsor

Suzhou Kintor Pharmaceutical Inc,